The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved January 1999

Specific Treatments:


Therapeutic Areas

General Information

Zofran ODT (odansetron) Orally Disintegrating Tablets have been approved for prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.


[ Home | Discussions | Article Archives | Help | Submit your Site]

Copyright 1996 - 2014 by Gelber Associates All Rights Reserved.